Senti Biosciences is a biotechnology company that develops gene circuits and therapies for treating various diseases. The company's platform uses synthetic biology and gene editing technologies to create gene circuits that can be programmed to detect and respond to specific signals in the body. Senti Biosciences is focused on developing therapies for cancer, autoimmune diseases, and genetic disorders. The company was founded in 2016 and is headquartered in South San Francisco, California.